PredictImmune Closes Series B Funding Round Raising £10M to Further Accelerate Global Commercial Expansion and Support Expanding Product Pipeline

New and existing investors demonstrate strong confidence in the developer of unique and pioneering prognostic tools to guide treatment of patients with immunemediated diseasesPredictImmune developers of pioneering prognostic tools for guiding treatment opt...